A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds XENEXENON PHARMACEUTICALS

10 funds on our shelf carry XENON PHARMACEUTICALS — heaviest hand: IBRN at 3.02% of its book.

FundWeightFund assetsShares held
IBRNiShares Neuroscience and Healthcare ETFINDEX3.02%$6M5,158
SMMViShares MSCI USA Small-Cap Min Vol Factor ETFINDEX0.57%$270M26,435
VTWGVanguard Russell 2000 Growth ETFINDEX0.37%$1B107,155
IBBiShares Biotechnology ETFINDEX0.25%$10.6B694,449
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.25%$112M6,905
IWOiShares Russell 2000 Growth ETFINDEX0.24%$14.4B920,387
VTWOVanguard Russell 2000 ETFINDEX0.18%$9.9B564,230
IWMiShares Russell 2000 ETFINDEX0.12%$79.3B2,560,600
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFINDEX0.03%$349M2,490
SPDWState Street SPDR Portfolio Developed World ex-US ETFINDEX0.01%$41B151,501

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.